Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00030563 · ClinicalTrials.gov registry record · Phase 2
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
A Phase 2 study of Colorectal Cancer and Metastatic Cancer, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Study locations
NCT00030563: Completed Phase 2 study of Colorectal Cancer and Metastatic Cancer, sponsored by University of Washington.
NCT00030563 is a Phase 2 study of Colorectal Cancer and Metastatic Cancer that has completed, run by University of Washington. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00030563, a Phase 2 study of Colorectal Cancer and Metastatic Cancer, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3
- Study locations
Study Summary
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving a chemotherapy drug after surgery and radiofrequency ablation may kill any remaining tumor cells. PURPOSE: Phase II trial to determine the effectiveness of surgery with or without radiofrequency ablation followed by irinotecan in treating patients who have colorectal cancer that is metastatic to the liver.
Conditions Studied
Interventions
- PROCEDURE conventional surgery
- PROCEDURE adjuvant therapy
- DRUG irinotecan hydrochloride
- PROCEDURE radiofrequency ablation
Study Locations (3)
Ohio
- Ireland Cancer Center - Cleveland
Washington
- University of Washington School of Medicine - Seattle
Ontario
- Princess Margaret Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-05 |
| Est. Completion | 2005-10 |
| Phase | Phase 2 |
What the finished NCT00030563 record still lists
NCT00030563 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 4 interventions - of which conventional surgery is the first listed.
NCT00030563 reports a single indexed study location in Ohio, Washington, Ontario.
Frequently Asked Questions
What is clinical trial NCT00030563 about?
NCT00030563 is a clinical study titled "Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver". RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving a chemotherapy dr...
What is the current status of trial NCT00030563?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-05. Estimated completion is 2005-10.
What conditions does trial NCT00030563 study?
This clinical trial studies the following conditions: Colorectal Cancer, Metastatic Cancer.
What interventions are being tested in trial NCT00030563?
The interventions under investigation include: conventional surgery (PROCEDURE), adjuvant therapy (PROCEDURE), irinotecan hydrochloride (DRUG), radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00030563?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00030563 being conducted?
This trial has 3 study locations across Ohio, Washington, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RECRUITING · Phase 2
-
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
RECRUITING · Phase 2
-
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
RECRUITING · Phase 2
-
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
RECRUITING · Phase 2
-
A Study of IBI363 in Subjects with Advanced Solid Malignancies
RECRUITING · Phase 2
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia